| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |